Expression of MMP2 in lung cancer at T3–4 stage (12/19, 63.2%) was higher than that in lung cancer at T1–2 stage (8/37, 21.6%) (p = 0.032) (Table 2, Fig. 2d). This evidence concerns the gene MMP2 and lung carcinoma.